Exhibiting strong activity in the life sciences and agri-tech fields, ES Shimron, I Molho, Persky & Co handles a significant volume of commercial work on behalf of start-ups, including advising on development agreements, licensing transactions, and clinical trials, among other issues. The team is also equipped to advise on company formation, funding rounds and corporate transactions. Practice head Shai Ganor specialises in VC and M&A work, while Dov Abramovitz is noted for his commercial and regulatory expertise. Also noted are Rachel Shay, Yakov Kohl and Shira Schlaff.
Testimonials
Collated independently by Legal 500 research team.
‘We had a very pleasant experience working with ES Shimron, I Molho, Persky & Co. The practice stood out for the personal engagement, and highly experienced partners that walked us through our first capital-raising process.’
‘We valued the availability and professionalism of the partners and associates we worked with, particularly David Shimron and Ofek Bruck.’
- ‘The hallmark of SMP lies not just in their legal prowess, but predominantly in their unwavering dedication to client care and service. While many firms can navigate the legal complexities, it stands out in its genuine commitment to treating start-ups not as mere clients, but as partners.’
- ‘The individuals truly set the firm apart. We had the pleasure of working with David Shimron and Ofek Bruk, whom carry a blend of profound legal expertise and an authentic human touch. Their approach isn't just transactional; they immerse themselves in our vision and become an integral part of our journey.’
Key clients
- N-Drip
- Bend It Technologies
- Alma Therapeutics
- Endoron Medical
- Migal Galilee Research Institute
- MigVax
- LycoRed Group of Companies
- Cellcom Israel
- Netafim
- Yossi Gross
- Amir Gross
- Quality In Flow
- Backbox Software
- Sea2Cell
- Triple P Training and Consulting
- Webbing
- Voye Global Connectivity
- Ag Bio Pro
- Alpine Quantum Technologies
Work highlights
- Advised N-Drip on its latest capital raising rounds in 2023, with closings in excess of $45m, including conversion of a SAFE round for $11m.
- Advised Endoron Medical on its capital raising round for approximately $8m, and on multiple transactions in connection with clinical trials.
- Advised Migal Galilee Research Institute on multiple research and licensing agreements between the commercial arm of Migal Galilee Research Institute and various start-up companies, for the licensing of technologies developed by Migal researchers to such companies.
Practice head
The lawyer(s) leading their teams.
Shai Ganor